Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin–paclitaxel doublet chemotherapy-Reference-Cited by-同舟云学术

Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin–paclitaxel doublet chemotherapy

Published:2012-08-16 Issue:5 Volume:20 Page:521-528
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Roulstone V,Twigger K,Zaidi S,Pencavel T,Kyula J N,White C,McLaughlin M,Seth R,Karapanagiotou E M,Mansfield D,Coffey M,Nuovo G,Vile R G,Pandha H S,Melcher A A,Harrington K J

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/gt201268.pdf

Reference24 articles.

1. Comins C, Heinemann L, Harrington K, Melcher A, De Bono J, Pandha H . Reovirus: viral therapy for cancer ‘as nature intended’. Clin Oncol (R Coll Radiol) 2009; 21: 204–217.

2. Yap T, Brunetto A, Pandha H, Harrington K, Debono JS . Reovirus therapy in cancer: has the orphan virus found a home? Expert Opin Investig Drugs 2008; 17: 1925–1935.

3. Harrington KJ, Vile RG, Melcher A, Chester J, Pandha HS . Clinical trials with oncolytic reovirus: moving beyond phase I into combinations with standard therapeutics. Cytokine Growth Factor Rev 2010; 21: 91–98.

4. Rosen L, Evans HE, Spickard A . Reovirus infections in human volunteers. Am J Hyg 1963; 77: 29–37.

5. Selb B, Weber B . A study of human reovirus IgG and IgA antibodies by ELISA and western blot. J Virol Methods 1994; 47: 15–25.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking the barriers in cancer care: The next generation of herpes simplex virus-based oncolytic immunotherapies for cancer treatment;Molecular Therapy - Oncolytics;2023-12

2. Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response;Frontiers in Cellular and Infection Microbiology;2023-03-15

3. Pre-treatment of oncolytic reovirus improves tumor accumulation and intratumoral distribution of PEG-liposomes;Journal of Controlled Release;2023-02

4. Oncolytic Viruses for the Treatment of Bladder Cancer: Advances, Challenges, and Prospects;Journal of Clinical Medicine;2022-11-26

5. Infection of non-cancer cells: A barrier or support for oncolytic virotherapy?;Molecular Therapy - Oncolytics;2022-03